Type 2 Diabetes Mellitus Clinical Trials in San Antonio, Texas

7 studies are recruiting for type 2 diabetes mellitus in San Antonio, Texas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

   Study ASC30-302 (AURORA-2) is a Phase III, global, multicenter, randomized, double-blind, placebo-controlled study to investigate the long-term efficacy, safety, and tolerability of three maintenance doses of once-daily oral ASC30 compared with placebo in participants with obesity or overweight and…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   AURORA-2 Clinical Site, San Antonio, Texas

   Locations

   135 in total

   Run by

   Ascletis Pharma (China) Co., Limited

   See if you can join NCT07743450 on ClinicalTrials.gov

2. A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

   The purpose of this study is to assess the efficacy and safety of enicepatide, a dual glucagon-like peptide-1 (GLP-1)/glucose-dependent insulinotropic polypeptide (GIP) receptor agonist (RA), at multiple doses compared with placebo for weight management in participants with obesity or overweight an…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Pinnacle Clinical Research - San Antonio, San Antonio, Texas

   Locations

   204 in total

   Run by

   Hoffmann-La Roche

   See if you can join NCT07351058 on ClinicalTrials.gov

3. A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus

   The purpose of this study is to evaluate the efficacy, safety, and tolerability of elecoglipron compared with oral semaglutide in adults with T2DM and increased cardiovascular risk that is inadequately managed alone or on stable treatment with other background glucose-lowering medication(s).

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Research Site, San Antonio, Texas

   Locations

   209 in total

   Run by

   AstraZeneca

   See if you can join NCT07662213 on ClinicalTrials.gov

4. A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin

   The purpose of this study is to evaluate the efficacy, safety, and tolerability of elecoglipron, compared with placebo in adults with type 2 diabetes mellitus (T2DM) and impaired renal function, who are or will be on a background of sodium-glucose cotransporter 2 inhibitor (SGLT2i) dapagliflozin 10…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Research Site, San Antonio, Texas

   Locations

   186 in total

   Run by

   AstraZeneca

   See if you can join NCT07662135 on ClinicalTrials.gov

5. A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus

   The purpose of this study is to evaluate the efficacy, safety, and tolerability of elecoglipron and dapagliflozin in combination, compared with elecoglipron alone and dapagliflozin alone, in adults with type 2 diabetes mellitus (T2DM) inadequately managed with lifestyle management alone or treated …

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Research Site, San Antonio, Texas

   Locations

   272 in total

   Run by

   AstraZeneca

   See if you can join NCT07662109 on ClinicalTrials.gov

6. A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin

   The purpose of this study is to evaluate the efficacy, safety, and tolerability of elecoglipron compared with placebo in adults with Type 2 Diabetes Mellitus (T2DM), treated with a background insulin and other background glucose-lowering medication(s)

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Research Site, San Antonio, Texas

   Locations

   132 in total

   Run by

   AstraZeneca

   See if you can join NCT07664553 on ClinicalTrials.gov

7. Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes

   A multi-center, 26-week randomized controlled trial (RCT) to evaluate the safety and efficacy of the fully closed loop Omnipod M System in adults with type 2 diabetes using basal/bolus insulin therapy or basal-only insulin therapy, with the primary endpoint after 15 weeks and secondary analysis at …

   Stage

   Not phased

   Ages

   18 to 75

   Site

   Tekton Research, San Antonio, Texas

   Locations

   27 in total

   Run by

   Insulet Corporation

   See if you can join NCT07521475 on ClinicalTrials.gov